Remove Heart attacks Remove Reimbursement Remove Strokes
article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

This condition poses a heightened risk for cardiovascular events, including heart attacks, strokes, and kidney problems. Dr. Kirtane echoes concerns about reimbursement, anticipating a potential impediment initially.

article thumbnail

Supercharging the ECG: AI set to Revolutionize the Diagnostic Cardiology Market

DAIC

Inevitably, given its fledgling status, regulation and reimbursement is still playing catch-up, though 2023 saw some important developments in this regard. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105
article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

Patients treated with CardiAMP cell therapy saw an almost 5% lower rate of heart death equivalents at up to two years compared to control patients treated with heart failure medication alone (8.3% The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. vs. 13.2%, respectively).